Optimization of myocardial perfusion after primary coronary angioplasty following an acute myocardial infarction. Beyond TIMI 3 flow

Journal of Invasive Cardiology

Volumn 18, Issue 1, 2006, Pages 32-36

  Hendler, Alberto ^a   Aronovich, Avi ^a   Kaluski, Edo ^a   Zyssman, Izhak ^a   Gurevich, Yosef ^a   Blatt, Alex ^a   Reicher, Meir ^a   Leitman, Marina ^a   Czuriga, Istvan ^a   Vered, Zvi ^a   Krakover, Ricardo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM; VERAPAMIL;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; FEMALE; HEART MUSCLE PERFUSION; HEART MUSCLE REPERFUSION; HUMAN; MALE; STATISTICAL ANALYSIS; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADENOSINE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NITROPRUSSIDE; PILOT PROJECTS; SINGLE-BLIND METHOD; STROKE VOLUME; TIME FACTORS; VASODILATOR AGENTS; VERAPAMIL;

EID: 33645841951     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ito H, Maryama A, et al. Lack of myocardial perfusion immediately after successful thrombolysis: Predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1996;93:223-228.
2. Abbo K, Dooris M, Glazier S, et al. Features and outcome of noreflow after percutaneous coronary intervention. Am J Cardiol 1995;75:778-782.
3. Gibson M, Cannon C, Murphy S, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000;101:125-130.
4. van't Hof A, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute MI. Myocardial blush grade. Circulation 1998;97:2302-2306.
5. Piana R, Park G, Moscucci M, et al. Incidence and treatment of noreflow after percutaneous coronary interventions. Circulation 1994;89:2514-2518.
6. Przyklenk K, Kloner RA. Reperfusion injury by oxygen delivered free radicals. Effect of superoxide dismutase plus catalase given at the time of reperfusion on myocardial infarct size, contractile function, coronary microvasculature and regional myocardial flow. Circ Res 1989;64:86-96.
7. Stahl LD, Aversano TR, Becker LC, et al. Selective enhancement of function of stunned myocardium by increase flow. Circulation 1986;74:843-851.
8. Stone G, Peterson M, Lansky A, et al. Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction. J Am Coll Cardiol 2002;39;4:591-597.
9. Pomerantz R, Kuntz R, Diver D, et al. Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm. Cathet Cardiovasc Diagn 1991;24:283-285.
10. Ishiara M, Sato H, Tateishi H, et al. Attenuation of the nonreflow after coronary angioplasty for acute myocardial infarction with intracoronary papaverin. Am Heart J 1996;132:959-963.
11. Kaplan B, Benzuly K, Kim J. Treatment of the non-reflow in degenerated saphenous vein grafts: comparison of intracoronary verapamil and nitroglycerin. Cathet Cardiovasc Diagn 1996;39:113-118.
12. Rawitscher D, Levin T, Cohen I, et al. Rapid reversal of nonreflow using abciximab after coronary intervention. Cathet Cardiovasc Diagn 1997;42:187-190.
13. Fischell TA, Carter AJ, Foster MT, et al. Reversal of non-reflow during vein graft stenting using high velocities boluses of intracoronary adenosine. Cathet Cardiovasc Diagn 1998;45:360-365.
14. Myers PR, Bann P, Guerra R, et al. Characteristics of canine coronary resistance arterioles: Importance of the endothelium. Am J Physiol 1989;257:H603-H610.
15. Kurz M, Lamping K, Bates J, et al. Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin. Circ Res 1991;68:847-855.
16. Bates J, Backer M, Guerra R, et al. Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required. Biochem Pharmacol 1991;42:5157-5165.
17. Jackson EK, Koehler M, Mi Z, et al. Possible role of adenosine in vaso-occlusive disease. J Hypert 1996;14:19-29.
18. Babbit DG, Virmani R, Forman MB, et al. Intracoronary adenosine administered after reperfusion, limits vascular injury after prolonged ischemia in the canine model. Circulation 1989;80:1288-1399.
19. Yoshiashi T, Hiroshi I, Katsuomi I, et al. Beneficial effect of intracoronary verapamil on microvascular and myocardial damage in patients with acute myocardial infarction. Circ Res 2001;37:347-351.
20. Kloner RA, Prynzklenk K. Experimental infarct size reduction with calcium channel blockers. J Am Coll Cardiol 1991;18:876-878.